Mds/aml Research Group

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

2 Citations (Scopus)

Azacitidine with or without lenalidomide in higher risk myelodysplastic syndrome & low blast acute myeloid leukemia

Kenealy, M., Hertzberg, M., Benson, W., Taylor, K., Cunningham, I., Stevenson, W., Hiwase, D., Eek, R., Zantomio, D., Jong, S., Wall, M., Blombery, P., Gerber, T., Debrincat, M., Zannino, D. & Seymour, J. F., 31 Mar 2019, In : Haematologica. 104, 4, p. 700-709 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission

Shanmuganathan, N., Braley, J. A., Yong, A., Hiwase, D., Yeung, D., Ross, D., Hughes, T. & Branford, S., 4 Jul 2019, In : Blood. 134, 1, p. 85-89 5 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: Prevalence, characteristic and significance

Chhetri, R., Wee, L. Y., Sinha, R., Kutyna, M. M., Pham, A., Stathopoulos, H., Nath, L., Nath, S. V., Wickham, N., Hughes, T., Singhal, D., Roxby, D. J. & Hiwase, D., 1 Jan 2019, In : Haematologica. 104, 10, p. E451-E454

Research output: Contribution to journalLetter